Drug Channels

APRIL 18, 2023

Like it or not, the Centers for Medicare & Medicaid Services (CMS) is barreling ahead with its implementation of the Inflation Reduction Act of 2022 (IRA). Last Friday was the last day to submit comments on CMS's initial guidance on the drug price negotiation program.

Drugs 87

Drugs Marketing Pharmacy Manufacturing 87

Drug Channels

JUNE 20, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: PBMs and the Battle Over Patient Support Funds: Accumulators, Maximizers, and Alternative Funding. Click here to see the original post from April 2023.

Drugs 84

Drugs Marketing Pharmacy Manufacturing 84

Medical Xpress

MARCH 13, 2023

Researchers surveyed 3,510 English-speaking adults living in five states as part of a Rutgers study

Research 80

Research 80

Scienmag

JANUARY 21, 2022

While both patients and clinicians prioritize information transparency, a 21st Century Cures Act requirement for the immediate release of test and lab results is proving more controversial, according to recently published survey results of clinicians and patients.

Research 88

Research 88

Pharmaceutical Technology

JANUARY 25, 2024

We speak with BAP Pharma to learn more about the challenges and possible benefits of medicines access solutions.

Medicine 130

Medicine 130

pharmaphorum

JANUARY 17, 2024

The disparity in access to healthcare between women and men around the world is often talked about but has never been given a dollar value – until now.

132

132

Worldwide Clinical Trials

APRIL 8, 2024

Enhanced CRA Training : It also allows Clinical Research Associates (CRAs) to receive tailored training and access ongoing support if needed, enhancing their capacity to monitor and ensure adherence to protocols and scale documentation. Learn more about our CAT services , and contact us to discuss how our in-house team can support your trial.

Clinical Research 165

Clinical Research Trials Clinical Trials Clinical Trials 165

pharmaphorum

FEBRUARY 20, 2024

Learn about the transparency of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) regarding medicines pricing and the Association of the British Pharmaceutical Industry (ABPI). Explore how these factors impact the pharmaceutical industry.

Branding 105

Branding Medicine 105

AuroBlog - Aurous Healthcare Clinical Trials blog

NOVEMBER 8, 2022

The National Institute of Mental Health and Neuro Sciences (NIMHANS) is concerned about the poor mental literacy levels and is working to reduce stigma around it. This could enable people to access care without any hesitation. The Institute sees stigma and discrimination as a major constraint to access mental healthcare.

Clinical Trials 152

Clinical Trials Clinical Trials Trials 152

Rethinking Clinical Trials

MARCH 7, 2024

The open-access article was published this week in Learning Health Systems. This responsibility arises from a key rationale for conducting pragmatic trials: that they can facilitate uptake of their results by relevant decision-makers.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Scientist 306

Scienmag

MAY 4, 2022

The UK Research and Innovation (UKRI) DARE UK (Data and Analytics Research Environments UK) programme has today published the findings of a UK-wide public dialogue exploring views towards data research practices, and where improvements need to be made to increase public confidence.

Research 66

Research 66

Pharmaceutical Technology

NOVEMBER 20, 2022

This news came as many organisations and patient advocacy groups have been campaigning for the adoption of some of the rejected drugs for several months, amidst concerns about access to medicines in the UK. At the time Amanda Pritchard, chief executive of NHS England, doubled down on the issue of medicine access. “If

Drugs 279

Drugs Medicine Antibody Clinical Trials 279

World of DTC Marketing

APRIL 20, 2022

We just finished talking to over 200 hundred HCPs about pharma marketing and salespeople to measure any differences since before the pandemic. Attitudes are indeed changing, but one need remains clear: access to data obtained during clinical and ongoing trials. To them, it was all about “getting the information I need quickly.”

Marketing 218

Marketing Drug Trials Drugs Sales 218

STAT News

MARCH 17, 2023

Louis, where STAT’s Usha Lee McFarling sat down with her to learn more about the changes she’s implemented at the journal, including a new open access policy. Bibbins-Domingo also spoke about what lies ahead for JAMA.

Life Science 138

Life Science Research 138

Pharmaceutical Technology

MAY 26, 2023

There are about 149 cell therapies in Phase I trials now , with additional 146 in Phase II studies, noted Chalk. Market access was also a key point of focus. According to a US-based key opinion leader (KOL) surveyed by GlobalData, access to cell therapies is still very low even in the US.

Marketing 264

Marketing Vaccination Vaccine Development 264

Drug Channels

APRIL 26, 2024

Kevin asks: What if there were no barriers across the therapy access and reimbursement process? Click here to learn more about CoverMyMeds’ comprehensive technology solutions. Today’s guest post comes from Kevin Kettler, President of CoverMyMeds. Meet CoverMyMeds in Booth 1305 at the Asembia AXS24 Summit.

Drugs 72

Drugs 72

Drug Channels

MARCH 28, 2024

Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Today’s guest post comes from Bill Dupere, SVP of Product Development & Partnerships at Mercalis. Read on for Bill’s insights.

Life Science 81

Life Science Marketing Production Development 81

Rethinking Clinical Trials

JANUARY 16, 2024

AIM-CP will address test a care management program to address inequities in access to nonpharmacological treatment for chronic pain in rural populations. Learn more about AIM-CP. Learn more about the MOMs Chat & Care Study. View the ethics and regulatory documentation for AIM-CP.

Trials 141

Trials Clinical Trials Clinical Trials 141

Fierce Pharma

SEPTEMBER 27, 2023

It’s been about 10 months since FDA inspectors rebuked a | As some cancer centers struggle to secure access to key platinum-based chemotherapies, a national spotlight gives the issue newfound political importance. But will this be a turning point for the recurrent shortage issue? ASCO's Julie Gralow, M.D., certainly hopes so.

113

113

BioTech 365

MARCH 12, 2021

Access-Power & Co., is pleased to announce we expect PCAOB completion by Friday April 2, 2021; A FORM 10 filing with the SEC right after the completion, and we expect to go OTC Market’s CURRENT INFORMATION on or about June … Continue reading →

40

40

Pharmaceutical Technology

DECEMBER 21, 2022

This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure. Additionally, the centre is anticipated to have to capacity to make up to 250 million doses of vaccines per year.

Gene Therapy 351

Gene Therapy Vaccination Vaccine Manufacturing 351

Rethinking Clinical Trials

APRIL 23, 2024

Infrequent cell phone use and lack of internet access were also associated with missing outcome assessments. Learn more about the NIH Collaboratory Trials. They found that younger age, public or no insurance, fewer comorbid conditions, and worse mental health function before injury were associated with lack of follow-up.

Research 152

Research Clinical Trials Clinical Trials Trials 152

STAT News

SEPTEMBER 6, 2022

This remarkable announcement about open access has the potential to remove information barriers that have long held back social and scientific progress. Even with immediate open access to research results, however, people with disabilities face unique barriers to information access.

Research 128

Research 128

Drug Channels

FEBRUARY 2, 2024

She highlights how GoodRx’s integrated pharma copay cards help to improve medication access, therapy adherence, and overall health outcomes. Click here to download the full report and learn more about partnering with GoodRx to drive patient access for your brand. Read on for Divya’s insights.

Branding 80

Branding Marketing Drugs Research 80

STAT News

DECEMBER 8, 2022

Doctors across the country, especially those in primary care, have been up in arms about Medicare’s proposed cuts in reimbursement that are scheduled to go into effect on January 1. Read the rest…

Doctors 143

Doctors Doctor 143

Pharmaceutical Technology

DECEMBER 27, 2022

In a recap of this eventful year, we take a moment to look at some of our biggest stories that relied on data and experts to inform our audience about the latest developments in the world of pharma, medical devices, and clinical trial operations. Tracking the news. Still, the country’s clinical trials sector remains insular.

Clinical Trials 306

Clinical Trials Clinical Trials Trials Vaccination 306

Drug Channels

MARCH 22, 2024

Adam discusses how patients seeking to access specialty therapies can benefit from a digital intake approach. To learn about AssistRx’s digital intake solutions, download Digital Intake for Specialty Drug Programs: Q1 2024 Progress Report. Today’s guest post comes from Adam Stotts, SVP of Customer Success at AssistRx.

Drugs 88

Drugs 88

Worldwide Clinical Trials

DECEMBER 7, 2023

Among the responses included: At Worldwide, we’re a CRO that prides ourselves on our personalized approach, providing direct access to our therapeutic experts while maintaining operational rigor. To learn more about our end-to-end services, contact us today.

Clinical Development 331

Clinical Development Clinical Trials Clinical Trials Trials 331

Drug Channels

FEBRUARY 16, 2024

Gavin discusses the problems manufacturers face in accessing and standardizing drug discount data. Today’s guest post comes from Gavin Magaha, Senior Director of Value Delivery at Kalderos. These data are necessary to avoid duplicate discounts and comply with regulatory requirements. Read on for Gavin’s insights. All rights reserved.

Drugs 80

Drugs Manufacturing 80

NPR Health - Shots

APRIL 10, 2023

Access to mifepristone, a medication that is used in about half of all abortions nationwide, hangs in the balance of two contradictory court rulings. A date with the Supreme Court is all but certain. Image credit: Allen G. Breed/AP)

105

105

STAT News

FEBRUARY 6, 2023

From concerns about the ethics of mental health influencers to the inaccuracy of mental health advice on TikTok and to complaints about teens misdiagnosing themselves , many experts are uncomfortable about the role technology is playing in mental health support.

98

98

Pharma Tutor

MAY 16, 2023

Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) : Making Quality Medicines Affordable and Accessible in India admin Tue, 05/16/2023 - 15:25 About Author Ramraj Choudhary M.Pharma, (Pharmaceutics) Dr. H.S Gour University, Sagar MP Current Position : Sr. Pharmacist, CGHS, MOHFW

Medicine 96

Medicine 96

Pharmacy Checkers

JULY 2, 2019

One of the Sustainable Development Goals, 3.8 , created under UN auspices is: “Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.” Title: Accelerator Discussion.

Medicine 49

Medicine Pharmacy Regulation Insulin 49

Medical Xpress

MAY 12, 2023

The findings, the researchers say, raise questions about who has access to medical education and could have negative impacts on patient care. Applicants and matriculants to U.S. medical schools in recent years have increasingly come from households with higher incomes, a new Yale-led study reveals.

Research 97

Research 97

Antidote

JANUARY 29, 2024

Not only will patients be able to gain access to potential new treatments, but they will also be directly contributing to research that can save lives — something that Jamie Troil Goldfarb has experienced firsthand. Jamie received a diagnosis of stage IV melanoma in 2011, only 11 weeks after giving birth to her child.

Clinical Trials 122

Clinical Trials Clinical Trials Trials Doctors 122

Drug Channels

NOVEMBER 10, 2023

Today’s guest post comes from James Pisano, Partner, Market Access at The Dedham Group and Dinesh Kabaleeswaran, SVP of Insights & Advisory Teams at MMIT. James and Dinesh offer four trends that they predict will shape medication access in the coming years.

Marketing 75

Marketing Drugs 75

Drug Channels

AUGUST 18, 2023

Divya discusses the challenges patients face in accessing specialty therapies prescribed by their healthcare providers. She suggests how the pharma industry can leverage GoodRx to help patients with access and affordability.

Business Development 78

Business Development Manufacturing Drugs Development 78